Condition: Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma · Sponsor: Medicenna Therapeutics, Inc.
This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.
This description comes directly from the study's public registry record.
Nina Merchant · 604-340-3081 · nmerchant@medicenna.com
Melissa Coello · 267-476-2313 · mcoello@medicenna.com
Always discuss trial participation with your own doctor first.
| Sharp Memorial Hospital | San Diego, California, United States | Recruiting |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | Active Not Recruiting |
| Providence Saint John's Health Center | Santa Monica, California, United States | Recruiting |
| Boca Raton Regional Hospital | Boca Raton, Florida, United States | Recruiting |
| Emory - Winship Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| Karmanos Cancer Institute | Detroit, Michigan, United States | Recruiting |
| MD Anderson Cancer Center | Houston, Texas, United States | Active Not Recruiting |
| Scientia Clinical Research | Randwick, New South Wales, Australia | Recruiting |
| Macquarie University | Sydney, New South Wales, Australia | Recruiting |
| University of the Sunshine Coast | Buderim, Queensland, Australia | Recruiting |
| Gallipoli Medical Research Foundation | Greenslopes, Queensland, Australia | Recruiting |
| Princess Margaret Cancer Center | Toronto, Ontario, Canada | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05086692